
Sign up to save your podcasts
Or
If you take a biologic drug to manage your arthritis, you might be facing some unexpected decisions as more competitors to brand-name biologics — called biosimilars — become available in the U.S. This year, at least eight biosimilars to the self-injectible biologic Humira are coming to market. Learn more about these drugs and what questions to ask your doctor and insurance company.
*Visit the Live Yes! With Arthritis Podcast episode page get show notes, additional resources and read the full transcript: https://www.arthritis.org/liveyes/podcast/new-podcast/ep-75-biosimilars-what-to-expect *
We want to hear from you. Tell us what you think about the Live Yes! With Arthritis Podcast. Get started by emailing [email protected].
Special Guest: Anna Hyde.
4.6
5858 ratings
If you take a biologic drug to manage your arthritis, you might be facing some unexpected decisions as more competitors to brand-name biologics — called biosimilars — become available in the U.S. This year, at least eight biosimilars to the self-injectible biologic Humira are coming to market. Learn more about these drugs and what questions to ask your doctor and insurance company.
*Visit the Live Yes! With Arthritis Podcast episode page get show notes, additional resources and read the full transcript: https://www.arthritis.org/liveyes/podcast/new-podcast/ep-75-biosimilars-what-to-expect *
We want to hear from you. Tell us what you think about the Live Yes! With Arthritis Podcast. Get started by emailing [email protected].
Special Guest: Anna Hyde.
1,698 Listeners
822 Listeners
12,526 Listeners
3,450 Listeners
7,509 Listeners
31,988 Listeners
3,358 Listeners
2,614 Listeners
9,305 Listeners
2,539 Listeners
2,006 Listeners
8,224 Listeners
20,784 Listeners
1,224 Listeners
308 Listeners